Recombination in the alphaherpesvirus bovine herpesvirus 1.
Herpesviruses are DNA viruses characterized by a low rate of nucleotide substitution. Therefore, other mechanisms must be involved to their evolution, like recombination that can be seen as an essential evolutionary driving force of these viruses. Recombination contributes to the long-term evolution of alphaherpesviruses. It acts also to continuously create new alphaherpesvirus strains. We have used bovine herpesvirus 1 to investigate recombination both within DNA concatemers in infected cells and in vitro and in vivo at the end of the lytic cycle. The following results have been obtained: (i) intramolecular recombination occurs at the level of concatemers and gives rise to genomic segment inversions; (ii) intraspecific recombination occurs frequently both in vitro and in vivo; (iii) interspecific recombination is possible and requires two highly genetically related viruses; (iv) only simultaneous or closely separated infections lead to the production of recombinant viruses; (v) recombination between wild-type and glycoprotein defective vaccine virus can produce a glycoprotein defective virus keeping part of the virulence of parental wild-type virus. Recombination, by exchanging genomic segments, may modify the virulence of alphaherpesviruses. It must be carefully assessed for the biosafety of antiviral therapy, alphaherpesvirus-based vectors and live attenuated vaccines.
Thiry
E
E
Department of Infectious and Parasitic Diseases, Virology and Immunology, Faculty of Veterinary Medicine, University of Liège, Bd de Colonster 20, B43b, B-4000 Liège, Belgium. etienne.thiry@ulg.ac.be
Muylkens
B
B
Meurens
F
F
Gogev
S
S
Thiry
J
J
Vanderplasschen
A
A
Schynts
F
F
D018138:Alphaherpesvirinae / Q000235:genetics / Q000472:pathogenicity; D000818:Animals; D004261:DNA Replication; D004279:DNA, Viral / Q000096:biosynthesis / Q000235:genetics; D005822:Genetic Vectors; D006566:Herpesviridae Infections / Q000662:veterinary* / Q000821:virology; D007242:Herpesvirus 1, Bovine / Q000235:genetics* / Q000472:pathogenicity; D011995:Recombination, Genetic; D012449:Safety; D014765:Viral Vaccines / Q000009:adverse effects / Q000235:genetics; D014774:Virulence / Q000235:genetics
D004279:DNA, Viral; D014765:Viral Vaccines